We just received data on a new analyst forecast for $BIO. RBC Capital gave a rating of 'Outperform' for $BIO.
$BIO Analyst Ratings
Wall Street analysts have issued reports on $BIO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 08/01/2025
- UBS issued a "Buy" rating on 05/02/2025
- Citigroup issued a "Buy" rating on 05/02/2025
To track analyst ratings and price targets for $BIO, check out Quiver Quantitative's $BIO forecast page.
$BIO Price Targets
Multiple analysts have issued price targets for $BIO recently. We have seen 4 analysts offer price targets for $BIO in the last 6 months, with a median target of $330.0.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $265.0 on 08/01/2025
- Conor McNamara from RBC Capital set a target price of $409.0 on 08/01/2025
- Dan Leonard from UBS set a target price of $310.0 on 05/02/2025
- Patrick Donnelly from Citigroup set a target price of $350.0 on 05/02/2025
$BIO Hedge Fund Activity
We have seen 184 institutional investors add shares of $BIO stock to their portfolio, and 270 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WEALTHFRONT ADVISERS LLC removed 1,043,153 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $254,070,344
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 852,685 shares (+119.5%) to their portfolio in Q1 2025, for an estimated $207,679,958
- FIRST PACIFIC ADVISORS, LP added 214,705 shares (+136.0%) to their portfolio in Q1 2025, for an estimated $52,293,549
- POINT72 ASSET MANAGEMENT, L.P. removed 212,906 shares (-86.0%) from their portfolio in Q1 2025, for an estimated $51,855,385
- SELECT EQUITY GROUP, L.P. removed 195,478 shares (-42.4%) from their portfolio in Q1 2025, for an estimated $47,610,621
- ARIEL INVESTMENTS, LLC added 164,136 shares (+29.3%) to their portfolio in Q1 2025, for an estimated $39,976,964
- GAMMA INVESTING LLC removed 147,107 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $35,499,861
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
